<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-93850</identifier>
<setSpec>1138-2074</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Alopecia areata and Down&#146;s syndrome</dc:title>
<dc:description xml:lang="en">The Down syndrome (DS) present different skin manifestations as: alopecia areata (AA), vitiligo, atopic dermatitis, pityriasis rubra pilaris, among others. AA is a chronic autoimmune inflammatory condition T-cell mediated against pilosebaceous follicle with stop of the anagen phase. AA is presented in 6-10% of patiens with DS (general population: 1.7%) and it is more frequent in women. Politherapy is more effective that monotherapy in the treatment of AA in that cases, and the prognosis is different depending of the clinical type of AA (AU)</dc:description>
<dc:creator>Alves, R</dc:creator>
<dc:creator>Ferrando, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome de Down (SD) presenta diversas manifestaciones dermatológicas; entre ellas, hay un aumento de incidencia de alopecia areata (AA), vitíligo, dermatitis atópica, foliculitis, acné, pitiriasis rubra pilar, entre otras. La AA se debe a un proceso inflamatorio crónico de origen autoinmune, mediado por células T que afectan al folículo piloso, lo que conlleva a la interrupción del ciclo folicular en la fase de anágeno. La incidencia de AA en pacientes con SD es del 6-10%, comparado con el 1,7% en la población general, y con predominio en el sexo femenino. El tratamiento comprende varias medidas, de las cuales la politerapia es más efectiva que la monoterapia, y el pronóstico es variable según la forma clínica de presentación (AU)</dc:description>
<dc:source>SD, Rev. med. int. Síndr. Down (Ed. castell.);15(3): 34-36, nov. 2011. ilus</dc:source>
<dc:identifier>ibc-93850</dc:identifier>
<dc:title xml:lang="es">Alopecia areata y síndrome de Down</dc:title>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d509^s22016</dc:subject>
<dc:subject>^d30164^s22073</dc:subject>
<dc:subject>^d7336^s22073</dc:subject>
<dc:subject>^d30934^s22012</dc:subject>
<dc:subject>^d32739^s22053</dc:subject>
<dc:subject>^d509^s22032</dc:subject>
<dc:subject>^d30934^s22056</dc:subject>
<dc:subject>^d9103^s22073</dc:subject>
<dc:subject>^d509^s22067</dc:subject>
<dc:subject>^d509^s22012</dc:subject>
<dc:subject>^d509^s22056</dc:subject>
<dc:type>article</dc:type>
<dc:date>201111</dc:date>
</metadata>
</record>
</ibecs-document>
